MADRIGAL PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

MADRIGAL PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $198.69 million for the year ending 2025.

  • MADRIGAL PHARMACEUTICALS, INC. showed an increase of +98.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from MADRIGAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 18 years of available data (2008 to 2025), MADRIGAL PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 281.8%.
  • Historical annual values: Fiscal year 2025: $198.69 million | Fiscal year 2024: $100.02 million | Fiscal year 2023: $99.92 million | Fiscal year 2022: $331.55 million | Fiscal year 2021: $36.27 million | Fiscal year 2020: $54.00 million | Fiscal year 2019: $46.70 million | Fiscal year 2018: $57.38 million | Fiscal year 2017: $148.63 million | Fiscal year 2016: $19.15 million | Fiscal year 2015: $306.0 thousand | Fiscal year 2014: $148.1 thousand | Fiscal year 2013: $48.49 million | Fiscal year 2012: $81.51 million | Fiscal year 2011: $30.08 million | Fiscal year 2010: $31.31 million | Fiscal year 2009: $44.16 million | Fiscal year 2008: $52.05 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: